MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-15-0008709
Consent Pharmaceuticals Private Limited
Consent Pharmaceuticals Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.59 Cr
▲ 62% YoY
Net profit · FY 2025
₹17.56 Lakh
Net margin 2.3%
EBITDA · FY 2025
₹34.46 Lakh
EBITDA margin 4.5%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹25.9 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
45
Provident fund records
About Consent Pharmaceuticals Private Limited
Data last updated:
Consent Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2017PTC058610. Its GSTIN is 08AAHCC1122F1Z6 (Rajasthan).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Ranjeeta and Hani Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.59 Cr, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹17.56 Lakh (net margin 2.3%) and EBITDA of ₹34.46 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 36% over five years.
The company has about 45 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25.9 Lakh on record.
Consent Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-15-0008709). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909RJ2017PTC058610
Registration Number 058610
Incorporation Date 21 July 2017
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-15-0008709
Recognitions & Rankings of Consent Pharmaceuticals
Contact details
Consent Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. G – 2 Plot No. 185 – 186, Alkapuri Township, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Consent Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Consent Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Consent Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Consent Pharmaceuticals Private Limited, buy the company report.
Financials of Consent Pharmaceuticals Private Limited
FY 2024 filings availableConsent Pharmaceuticals Private Limited reported revenue of ₹7.59 Cr (up 62% YoY) for FY 2025.
Revenue · FY 2025
₹7.59 Cr ▲ 62%
Net profit · FY 2025
₹17.56 Lakh margin 2.3%
EBITDA · FY 2025
₹34.46 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 62%
3 years · compounded
▲ 25%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 84%
3 years · compounded
▲ 31%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 62% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Consent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Consent Pharmaceuticals Private Limited
Consent Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjeeta | Director | 21 Jul 2017 | 9 Years 3 Months | Current |
| Hani Sharma | Director | 18 Dec 2020 | 5 Years 10 Months | Current |
| Kuldeep Also directs: Sazum Healthcare Private Limited | Director | 18 Dec 2020 | 5 Years 10 Months | Current |
| Sandeep Kumar Gera | Director | 21 Jul 2017 | 9 Years 3 Months | Current |
Auditor
Consent Pharmaceuticals Private Limited is audited by MODI AGRAWAL & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MODI AGRAWAL & ASSOCIATES LLP | FY 2023 | C400303 |
Shareholding
The shareholding of Consent Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Consent Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25.9 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jan 2024 | 100871974 | Others | ₹10 Lakh | Open | |
| 19 Jul 2019 | 100278556 | Axis Bank Limited | ₹15.9 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Consent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Consent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Consent Pharmaceuticals Private Limited has a workforce of 45 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
45
Active EPFO establishments
1
Employee growth
18.42%
GST
Consent Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCC1122F1Z6 | Rajasthan | Active | 06 Nov 2017 |
To see the full GST registrations and return filing status of Consent Pharmaceuticals Private Limited, buy the company report.
Recent activity
Consent Pharmaceuticals Private Limited has 7 board changes on record since 2017: 4 appointments and 3 cessations. The latest: Sunil Chugh ceased to be Director on 18 Aug 2023.
AGM
Consent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Consent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100871974 was registered on 02 Jan 2024.
Ceased
Sunil Chugh ceased to be Director.
Ceased
Hani Sharma ceased to be Additional Director.
Ceased
Kuldeep ceased to be Additional Director.
Appointed
Hani Sharma was appointed as Director.
Appointed
Kuldeep was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 15.90 Lakh with Charge ID 100278556 was registered on 19 Jul 2019.
Appointed
Ranjeeta was appointed as Director.
Appointed
Sandeep Kumar Gera was appointed as Director.
Incorporation
21 Jul 2017
Consent Pharmaceuticals Private Limited was registered on 21 Jul 2017 with Roc Jaipur & aged 9 years 3 months as per MCA records.
Frequently asked questions
Consent Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2017 (9+ years old) and is registered under CIN U51909RJ2017PTC058610.
Consent Pharmaceuticals has 4 current directors:
- Ranjeeta - Director
- Hani Sharma - Director
- Kuldeep - Director
- Sandeep Kumar Gera - Director
The latest financial statements of Consent Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Consent Pharmaceuticals is 08AAHCC1122F1Z6, registered in Rajasthan.
The CIN (Corporate Identification Number) of Consent Pharmaceuticals is U51909RJ2017PTC058610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Consent Pharmaceuticals was incorporated on 21 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
Sunil Chugh ceased to be Director on 18 Aug 2023. Hani Sharma ceased to be Additional Director on 31 Dec 2020. Kuldeep ceased to be Additional Director on 31 Dec 2020. Consent Pharmaceuticals has 7 board changes on record in total.
Yes, Consent Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-15-0008709).
The registered office of Consent Pharmaceuticals is at Flat No. G – 2 Plot No. 185 – 186, Alkapuri Township, Jaipur, Rajasthan, India – 302012.
Consent Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.